Blocknomi
TLDR Moderna shares plunged 24.56% despite positive Phase III melanoma trial results. Jefferies models $54 billion in global peak sales for Moderna’s cancer therapy. The melanoma study met recurrence-free and…
Related articles
-
Binance Wallet Introduces One-Tap LP via BNB Smart Chain
BlockchainReporter Published 07.08.2026 15:00
-
SpaceX (SPCX) Stock Climbs as First Lockup Expiration Fails to Trigger Selloff
Blocknomi Published 10.08.2026 11:57
-
SEC Proposes Crypto Fundraising Exemptions in Abrupt About-Face
Decrypt Published 18.08.2026 20:00
-
Cardano price nears $0.17 despite Dijkstra roadmap
Crypto.News Published 17.08.2026 21:00
-
Hedge Funds Double Down on U.S. Stocks as Tech Buying Surges
Blocknomi Published 18.08.2026 22:25
-
This Public Company Quietly Controls 20% of Ethena’s ENA Supply
Bitcoin.com Published 16.08.2026 16:50
-
Bitcoin has ‘largely purged’ froth that preceded 50% drop from $126K: BlackRock
Cointelegraph Published 19.08.2026 11:06
-
XRP (XRP) Price: Drops 69% Below January 2025 Peak
Blocknomi Published 14.08.2026 10:18